Knowledge graph · Variant
FCGR2A H167R
SNV
- Identifier
- CI-VAR-00001897
- Entity page
- /variant/fcgr2a-h167r ↗
- Edges
- 3
- Neighbours
- 2 cancers1 drugs
- Drawn
- 3 of 3 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,149Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| FCGR2A H167R predicts response to …PREDICTS_RESPONSE_TOderived1 of 1 | ||||||||
| → predicts response to | Trastuzumabmonoclonal antibody 1 accepted predictive items (aggregated from CIViC, no knowledge edge yet) | sensitivity | B | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| FCGR2A H167R has curated evidence in …HAS_EVIDENCE_IN | ||||||||